Bausch Health Companies | VRX - Market Capitalization


Bausch Health Companies reported $4.09B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 247.94B 20.06B Nov/2026
ANI Pharmaceuticals USD 1.46B 206M Nov/2026
Aurora Cannabis CAD 318.09M 145.93M Nov/2026
Bausch Health Companies USD 4.13B 1.95B Nov/2026
Biogen USD 33.38B 1.48B Sep/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Canopy Growth CAD 88.38M 494.19M Nov/2026
Corcept Therapeutics USD 8.58B 3.87B Nov/2026
Danaher USD 157.81B 18.96B Sep/2026
Drreddys Laboratories INR 2.29B 8.43B Nov/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 1.69B 695M Nov/2026
Perrigo USD 2.17B 31M Nov/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.2B 38M Nov/2026
Supernus Pharmaceuticals USD 2.51B 193M Sep/2026
Vertex Pharmaceuticals USD 142.88B 10.37B Nov/2026
Zoetis USD 37.6B 8.74B Nov/2026